|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Metabolite or derivative |
| Approved drug? | Yes (source: FDA (no history prior to 1951)) |
IUPAC Name ![]() |
| 4-[(1R)-1-hydroxy-2-methylaminoethyl]benzene-1,2-diol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 2142 | epinephrine |
| 4553 | racepinefrine |
Synonyms ![]() |
| adrenalin |
| Auvi-Q® |
| Epipen® |
| l-adrenaline |
| L-epinephrine |
| levoepinephrine |
Database Links ![]() |
|
| BindingDB Ligand | 50029050 |
| CAS Registry No. | 51-43-4 |
| ChEBI | CHEBI:28918 |
| ChEMBL Ligand | CHEMBL679 |
| DrugBank Ligand | DB00668 |
| Human Metabolome Database | HMDB00068 |
| PharmGKB Drug | PA449470 |
| PubChem CID | 5816 |
| RCSB PDB Ligand | ALE |
| Search Google for chemical match using the InChIKey | UCTWMZQNUQWSLP-VIFPVBQESA-N |
| Search Google for chemicals with the same backbone | UCTWMZQNUQWSLP |
| Search PubMed clinical trials | racepinefrine |
| Search PubMed titles | racepinefrine |
| Search PubMed titles/abstracts | racepinefrine |
| Wikipedia | Epinephrine |
| Comments |
| Agonist at alpha and beta adrenoceptors. In addition to being assigned the INN epinephrine in its own right, (-)-adrenaline is also one of the enantiomers found in the INN-assigned compound (±)-adrenaline. |